After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Artificial intelligence is revolutionizing drug development, significantly reducing the time it takes to bring life-saving ...

Researchers at the University created an AI model called EZSpecificity to test how certain enzymes and substrates bind to ...

The FDA approved a drug made by Kura Oncology to treat patients with a certain type of genetically altered leukemia.

Lantern Pharma Inc. (NASDAQ:LTRN) is set to showcase two of its commercially deployed artificial intelligence platforms at the University of North Texas’ inaugural AI for Biology and Medicine (AI4BM) ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Pfizer noted it has completed its acquisition of all outstanding shares of the company’s common stock for $65.60 per share in ...

Drug-discovery platforms, technologies that analyze drug candidates, are being combined with AI and machine learning to ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

What does Rick Pazdur's new role mean for the FDA? And how much credit can the president take for lowering GLP-1 drug prices?